Home » EMA: Use of Off-Label, Unauthorized Medicines for Children Needs Attention
EMA: Use of Off-Label, Unauthorized Medicines for Children Needs Attention
The widespread use of off-label and unauthorized medicines to treat children in Europe requires regulatory review, according to a report published by the European Medicines Agency (EMA). Between 45 and 60 percent of the total number of prescriptions written are off-label and unauthorized in both hospital and outpatient settings, according to the report. The highest rates of off-label and unauthorized drug use were associated with premature, term neonates and infants, as well as children with very severe conditions.
International Pharmaceutical Regulatory Monitor
International Pharmaceutical Regulatory Monitor
Upcoming Events
-
07May
-
14May
-
30May